CN103163272A - Quality control method of infant spleen tonifying medicament - Google Patents

Quality control method of infant spleen tonifying medicament Download PDF

Info

Publication number
CN103163272A
CN103163272A CN2013101106827A CN201310110682A CN103163272A CN 103163272 A CN103163272 A CN 103163272A CN 2013101106827 A CN2013101106827 A CN 2013101106827A CN 201310110682 A CN201310110682 A CN 201310110682A CN 103163272 A CN103163272 A CN 103163272A
Authority
CN
China
Prior art keywords
solution
methyl alcohol
reference substance
medicinal material
add
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2013101106827A
Other languages
Chinese (zh)
Other versions
CN103163272B (en
Inventor
王六贵
吕建英
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanxi Zhendong wuhetang Pharmaceutical Co.,Ltd.
Original Assignee
Shanxi Zhendong Kaiyuan Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanxi Zhendong Kaiyuan Pharmaceutical Co Ltd filed Critical Shanxi Zhendong Kaiyuan Pharmaceutical Co Ltd
Priority to CN201310110682.7A priority Critical patent/CN103163272B/en
Publication of CN103163272A publication Critical patent/CN103163272A/en
Application granted granted Critical
Publication of CN103163272B publication Critical patent/CN103163272B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The invention discloses a quality control method of an infant spleen tonifying medicament. According to the method, hawthorn and licorice in the medicament are identified by using layer chromatography respectively, and the hesperidin content of the medicament is measured by using liquid chromatography. In the established quality control method, the medicinal material identification method is mature, feasible, high in specificity, negative and non-interfering; the content measurement method is easy to operate, high in precision and high in reproducibility; and by adopting the quality control method, the quality of the medicament can be accurately and stably controlled to adapt to industrialized stable production of the medicament.

Description

A kind of method of quality control of infant spleen-tonifying medicine
Technical field
The present invention relates to a kind of Chinese medicine for infant spleen-tonifying, particularly relate to the method for quality control of this medicine.
Background technology
It is the medication of paediatrics class that children's joins the art Jianpi Wan, is used for the spleen and stomach in children weak, and indigestion is lean and haggard, lassitude.
Children's joins the existing operative norm of art Jianpi Wan and includes in the 5th of the Sanitation Ministry medicine standard Traditional Chinese medicine historical preparation.Formulated following content in this quality standard.
Get this product, put microscopically and observe: irregular branched agglomerate is colourless, meets chloral hydrate liquid and dissolves; Hyphae colorless or light brown, diameter 4-6 μ m.Connect latex dust diameter 12-15 μ m, contain fine particle shape thing.The pericarp lithocyte is single be dispersed in or minority in groups, lilac red, redness or yellowish-brown, similar round or polygon.Plant the long 80-150 μ of skin palisade cells m.Around fibrous bundle, parenchyma cell contains the calcium oxalate prismatic crystal, forms crystal fiber.
Check, should meet relevant every regulation under the pill item.
Above-mentioned quality standard exists more serious defective: at first, this standard is not carried out the quantitative measurement of active constituent content for main medicine; Secondly, the composition medicine more than 50% does not all carry out the chemistry discriminating.
Chinese medicine preparation steady quality, controlled and have that to produce repeatability be the premise that medicine has pharmacology and clinical effectiveness repeatability, can traditional Chinese medicine quality controlled and whether the traditional Chinese medicine quality standard is scientific, is the important restriction factor that affects industrialization of Chinese medicine.Quality controllability is the important indicator that medicine is estimated, and quality standard is the imbody of drug quality controllability.
Summary of the invention
The method of quality control that the purpose of this invention is to provide a kind of above-mentioned infant spleen-tonifying medicine is stablized controlled with the drug quality of guaranteeing to produce.
The method of quality control of infant spleen-tonifying medicine provided by the invention is suitable for the medicine that is prepared from by following bulk drug: Radix Codonopsis, stir-baked RHIZOMA ATRACTYLODIS MACROCEPHALAE with soil, Radix Glycyrrhizae (processed with honey), bran stir-baked SEMEN EURYALES, soil are fried that Semen Lablab Album, Rhizoma Dioscoreae (parched with bran), soil are fried Semen Nelumbinis, dried orange peel, fried hawthorn, bran is fried Medicated Leaven, are fried Fructus Hordei Germinatus, Poria cocos, soil are fried coix seed.Described method of quality control comprises discrimination method and content assaying method.
Wherein, described discrimination method comprises following discriminating:
1) get described medicine 10g, add zeyssatite 5g, grind well, the 40ml that adds diethyl ether, ultrasonic processing 15 minutes, filter, discard ether solution, the dregs of a decoction add ethyl acetate 40ml, and ultrasonic processing 15 minutes filters, the dregs of a decoction are standby, and filtrate evaporate to dryness, residue add methyl alcohol 2ml makes dissolving, as need testing solution; Separately get hawthorn control medicinal material 1g, with the standby control medicinal material solution of legal system; Separately get the ursolic acid reference substance, add methyl alcohol and make the solution that every 1ml contains 1mg, in contrast product solution; According to the thin-layered chromatography test, draw need testing solution 10 μ l, control medicinal material solution 5 μ l, reference substance solution 2 μ l put respectively on same silica gel g thin-layer plate, and take toluene: ethyl acetate: formic acid=20:4:0.5 is as developping agent, launch, take out, dry, spray is with 10% ethanol solution of sulfuric acid, be heated to the spot colour developing at 105 ℃ clear, in the test sample chromatogram, with reference substance chromatogram corresponding position on, aobvious identical aubergine spot;
2) get 1) in residue after ethyl acetate extraction, fling to ethyl acetate, add methyl alcohol 30ml, add hot reflux 1 hour, and filtered the filtrate evaporate to dryness, residue adds water 40ml makes dissolving, extracts 3 times with water-saturated n-butanol, each 20ml, merge normal butyl alcohol liquid, with the saturated water washing of normal butyl alcohol 3 times, each 15ml, normal butyl alcohol liquid is recycled to dried, residue adds methyl alcohol 5ml makes dissolving, as need testing solution; Another extracting Radix Glycyrrhizae control medicinal material 1g adds methyl alcohol 20ml, is made in the same way of control medicinal material solution; According to the thin-layered chromatography test, draw need testing solution 10 μ l, control medicinal material solution 5 μ l, put respectively on same silica gel g thin-layer plate, take methenyl choloride: acetone: formic acid=8:1:0.1 launches as developping agent, take out, dry, spray is heated to the spot colour developing at 105 ℃ clear with aluminum trichloride solution, put under the 365nm ultraviolet lamp and inspect, in the test sample chromatogram, with control medicinal material chromatogram corresponding position on, the fluorescence spot of aobvious same color.
Described content assaying method comprises the mensuration of content of hesperidin.
The present invention is specifically with the content of the described aurantiamarin of following high effective liquid chromatography for measuring:
1) chromatographic condition and system suitability: take octadecylsilane chemically bonded silica as filling agent, take methyl alcohol: water=40:60 as mobile phase; Detect wavelength 283nm; Number of theoretical plate calculates by aurantiamarin and is not less than 3000;
2) preparation of reference substance solution: get the aurantiamarin reference substance appropriate, accurately weighed, add methyl alcohol and make the reference substance solution that every 1ml contains 50 μ g;
3) preparation of need testing solution: get described medicine, porphyrize, mixing is got 0.8g, accurately weighed, add zeyssatite 0.4g, grind well, put in tool plug conical flask, precision adds methyl alcohol 25ml, close plug, weighed weight, the ultrasonic processing of power 200W, frequency 40kHz 30 minutes lets cool, weighed weight is again supplied the weight of less loss with methyl alcohol, shake up, filter, get subsequent filtrate, and get final product;
4) draw respectively each 10 μ l of reference substance solution and need testing solution, the injection liquid chromatography is measured and get final product.
The present invention has set up the method for quality control of infant spleen-tonifying medicine, in the method for setting up, the discrimination method mature and feasible of medicinal material, specificity is strong, and is negative noiseless, the content assaying method processing ease, precision is high, favorable reproducibility uses method of quality control of the present invention can accurately, stably control the drug quality that children's joins the art Jianpi Wan, to adapt to the industrialization steady production of medicine.
Embodiment
Embodiment 1: the thin layer of hawthorn is differentiated.
Get children's and join art Jianpi Wan 10g, add zeyssatite 5g, grind well, the 40ml that adds diethyl ether, ultrasonic processing 15 minutes filters, and the dregs of a decoction add ethyl acetate 40ml, and ultrasonic processing 15 minutes filters, and filtrate evaporate to dryness, residue add methyl alcohol 2ml dissolving, as need testing solution; With the standby negative sample solution of legal system; Separately get hawthorn control medicinal material 1.0g, with the standby control medicinal material solution of legal system; Separately get the ursolic acid reference substance, add methyl alcohol and make the solution that every 1ml contains 1mg, in contrast product solution.According to thin-layered chromatography (" appendix VI B of Chinese pharmacopoeia version in 2010) test, draw negative sample solution 10 μ l, need testing solution 10 μ l, control medicinal material solution 5 μ l, reference substance solution 2 μ l put respectively on same silica gel g thin-layer plate, take toluene-ethyl acetate-formic acid (20:4:0.5) as developping agent, launch, take out, dry, spray the ethanol solution of sulfuric acid with 10%, be heated to the spot colour developing at 105 ℃ clear, put under daylight and inspect.
As a result, in the test sample chromatogram, with reference substance and control medicinal material chromatogram corresponding position on, the aubergine spot of aobvious same color on negative sample chromatogram corresponding position, is speckless, and illustrate that feminine gender is noiseless, specificity is strong.
Embodiment 2: the thin layer of Radix Glycyrrhizae is differentiated.
Get children's and join art Jianpi Wan 10g, add zeyssatite 5g, grind well, 40ml adds diethyl ether, ultrasonic processing 15 minutes filters, and the dregs of a decoction add ethyl acetate 40ml, ultrasonic processing 15 minutes, filter, the dregs of a decoction add methyl alcohol 30ml, add hot reflux 1 hour, filter, filtrate evaporate to dryness, residue add water 40ml makes dissolving, extracts 3 times with normal butyl alcohol, each 20ml merges normal butyl alcohol liquid, washes with water 3 times, evaporate to dryness, residue add methyl alcohol 5ml makes dissolving, as need testing solution; With the standby negative sample solution of legal system; Another extracting Radix Glycyrrhizae control medicinal material 1g is made in the same way of control medicinal material solution.According to thin-layered chromatography (" appendix VI B of Chinese Pharmacopoeia 2005 version) test, draw need testing solution 10 μ l, control medicinal material solution 6 μ l, negative sample solution 10 μ l, put respectively on same silica gel g thin-layer plate, take methenyl choloride-acetone-formic acid (8:1:0.1) as developping agent, launch, take out, dry, spray is heated to the spot colour developing at 105 ℃ clear with aluminum trichloride solution, puts under ultraviolet lamp (365nm) and inspects.
In the test sample chromatogram, with control medicinal material chromatogram corresponding position on, have three places corresponding, aobvious identical blueness, yellow green, green fluorescence spot respectively from top to bottom, negative noiseless, specificity is strong.
Embodiment 3: the mensuration of content of hesperidin.
Children's joins the art Jianpi Wan and is comprised of the 13 flavor Chinese medicines such as Radix Codonopsis, the bighead atractylodes rhizome, Radix Glycyrrhizae, Gorgon fruit, Semen Lablab Album, Chinese yam, Semen Nelumbinis, dried orange peel, and primary standard is without the assay item.For the better monitoring of controlling the quality of the pharmaceutical preparations and realizing technological process, the aurantiamarin in selected dried orange peel is as the assay index.
1, instrument and reagent.
Waters2695-2487 high efficiency liquid phase spectrometer, chromatographic work station (U.S. Waters company); Aurantiamarin reference substance (lot number 0721-200010, Nat'l Pharmaceutical ﹠ Biological Products Control Institute); Methyl alcohol: chromatographically pure (α Cygni friend fine chemicals company limited); Water: pure water; It is pure that zeyssatite and other reagent are analysis.
Children's joins the art Jianpi Wan.
2, chromatographic condition.
Chromatographic column: YMC-Pack ODS-A(4.6mm * 250mm); Mobile phase: methanol-water (40:60); Flow velocity: 1.0ml/min; Detect wavelength: 283nm; Column temperature: 35 ℃.Number of theoretical plate calculates by aurantiamarin and is not less than 3000.
3, the preparation of reference substance solution.
Get the aurantiamarin reference substance appropriate, accurately weighed, add methyl alcohol and make the reference substance solution that every 1ml contains 50 μ g.
4, the preparation of need testing solution.
Get children's and join art Jianpi Wan porphyrize, mixing is got 0.8g, accurately weighed, add zeyssatite 0.4g, grind well, put in tool plug conical flask, precision adds methyl alcohol 25ml, close plug, weighed weight, ultrasonic processing (power 200W, frequency 40kHz) 30 minutes lets cool, weighed weight is again supplied the weight of less loss with methyl alcohol, shake up, filter, get subsequent filtrate, and get final product.
5, the mensuration of content of hesperidin.
Precision is drawn reference substance solution and each 10 μ l of need testing solution respectively, and the injection liquid chromatography is measured, and be get final product.
6, negative sample test.
Join art Jianpi Wan preparation prescription ratio in children's, the negative control sample of dried orange peel is removed in the preparation of simulation process method for making.Precision takes negative control sample 3g, makes negative need testing solution by the need testing solution preparation method.Under chromatographic condition, record respectively the chromatogram of aurantiamarin reference substance, test sample and negative control product, the collection of illustrative plates result shows: with the corresponding section of aurantiamarin retention time, occur without chromatographic peak in negative control product chromatogram, namely under the condition determination of determining, in preparation prescription, other flavour of a drug are noiseless to the mensuration of aurantiamarin, and the method specificity is strong.
7, the investigation of linear relationship.
Get aurantiamarin reference substance storing solution (measuring bottle sealing, freezing preservation, concentration 0.1002mg/ml), put to room temperature, check whether less loss of solution, shake up, filter.Accurate reference substance solution 2,4,6,10,15, the 20 μ l of drawing, twice of each parallel sample introduction, measure peak area, take the average peak area integrated value as ordinate, aurantiamarin reference substance sample size is that horizontal ordinate calculates regression equation, and getting regression equation is y=1815.7x-14240, r=0.99995, show that aurantiamarin sample size and peak area in the 200.4-2004ng scope are good linear relationship, see Table 1.
8, precision test.
The accurate need testing solution of drawing, continuous sample introduction 6 times, each 10 μ l, measurement result such as table 2, RSD show that less than 3% precision is higher, and reliability is strong, and method is feasible.
Figure 417628DEST_PATH_IMAGE002
9, stability test.
Get children's and join art Jianpi Wan 3g, accurately weighed, add zeyssatite 1.5g, grind well, to put in 50ml tool plug conical flask, precision adds methyl alcohol 25ml, close plug, weighed weight, ultrasonic processing 1 hour after letting cool, is supplied less loss weight with methyl alcohol, shakes up, and filters, and gets subsequent filtrate.Draw need testing solution 10 μ l 0,1,2,4,6,8 hour precision respectively, the injection liquid chromatography is measured, and the results are shown in Table 3, and need testing solution is stable in 8 hours, and the RSD value is less than 3%.
Figure 616528DEST_PATH_IMAGE003
10, replica test.
Get same lot number sample (lot number: 081016) 0.8g, accurately weighed, extract by the need testing solution preparation method respectively, assay calculates.Average content is 1.561mg/ml as a result, and RSD is 1.63%, the results are shown in Table 4, shows that the method reappearance is good.
Figure 98456DEST_PATH_IMAGE004
11, average recovery test.
Precision takes aurantiamarin reference substance 9.22mg, adds methyl alcohol and dissolves and be diluted to 100ml, shakes up, and filters, and makes reference substance solution, and every ml contains aurantiamarin 0.0922mg.
The accurate reference substance solution 6.5ml that draws puts in the 50ml conical flask, and evaporate to dryness is with standby 6 parts of legal system.Take 6 parts of the same batch samples of known content (1.561mg/g), every part of about 0.4g, accurately weighed, add zeyssatite 0.2g, grind well, be transferred in conical flask, precision adds methyl alcohol 25ml respectively, close plug, weighed weight, ultrasonic processing 30 minutes lets cool, and supplies the weight of less loss with methyl alcohol, shake up, filter, get subsequent filtrate, make need testing solution.
Accurate above-mentioned reference substance solution 5 μ l, need testing solution 10 μ l, injection liquid chromatography, the mensuration drawn.Calculate recovery rate, result such as table 5, the average recovery rate of aurantiamarin are that 97.34%, RSD is 1.27%.

Claims (2)

1. the method for quality control of an infant spleen-tonifying medicine, described infant spleen-tonifying medicine is the medicine that is prepared from by following bulk drug: Radix Codonopsis, stir-baked RHIZOMA ATRACTYLODIS MACROCEPHALAE with soil, Radix Glycyrrhizae (processed with honey), bran stir-baked SEMEN EURYALES, soil are fried that Semen Lablab Album, Rhizoma Dioscoreae (parched with bran), soil are fried Semen Nelumbinis, dried orange peel, fried hawthorn, bran is fried Medicated Leaven, are fried Fructus Hordei Germinatus, Poria cocos, soil are fried coix seed, it is characterized in that the discrimination method in described method of quality control comprises following discriminating:
1) get described medicine 10g, add zeyssatite 5g, grind well, the 40ml that adds diethyl ether, ultrasonic processing 15 minutes, filter, discard ether solution, the dregs of a decoction add ethyl acetate 40ml, and ultrasonic processing 15 minutes filters, the dregs of a decoction are standby, and filtrate evaporate to dryness, residue add methyl alcohol 2ml makes dissolving, as need testing solution; Separately get hawthorn control medicinal material 1g, with the standby control medicinal material solution of legal system; Separately get the ursolic acid reference substance, add methyl alcohol and make the solution that every 1ml contains 1mg, in contrast product solution; According to the thin-layered chromatography test, draw need testing solution 10 μ l, control medicinal material solution 5 μ l, reference substance solution 2 μ l put respectively on same silica gel g thin-layer plate, and take toluene: ethyl acetate: formic acid=20:4:0.5 is as developping agent, launch, take out, dry, spray is with 10% ethanol solution of sulfuric acid, be heated to the spot colour developing at 105 ℃ clear, in the test sample chromatogram, with reference substance chromatogram corresponding position on, aobvious identical aubergine spot;
2) get 1) in residue after ethyl acetate extraction, fling to ethyl acetate, add methyl alcohol 30ml, add hot reflux 1 hour, and filtered the filtrate evaporate to dryness, residue adds water 40ml makes dissolving, extracts 3 times with water-saturated n-butanol, each 20ml, merge normal butyl alcohol liquid, with the saturated water washing of normal butyl alcohol 3 times, each 15ml, normal butyl alcohol liquid is recycled to dried, residue adds methyl alcohol 5ml makes dissolving, as need testing solution; Another extracting Radix Glycyrrhizae control medicinal material 1g adds methyl alcohol 20ml, is made in the same way of control medicinal material solution; According to the thin-layered chromatography test, draw need testing solution 10 μ l, control medicinal material solution 5 μ l, put respectively on same silica gel g thin-layer plate, take methenyl choloride: acetone: formic acid=8:1:0.1 launches as developping agent, take out, dry, spray is heated to the spot colour developing at 105 ℃ clear with aluminum trichloride solution, put under the 365nm ultraviolet lamp and inspect, in the test sample chromatogram, with control medicinal material chromatogram corresponding position on, the fluorescence spot of aobvious same color.
2. the method for quality control of infant spleen-tonifying medicine according to claim 1 is characterized in that content assaying method in described method of quality control is the content with following high effective liquid chromatography for measuring aurantiamarin:
1) chromatographic condition and system suitability: take octadecylsilane chemically bonded silica as filling agent, take methyl alcohol: water=40:60 as mobile phase; Detect wavelength 283nm; Number of theoretical plate calculates by aurantiamarin and is not less than 3000;
2) preparation of reference substance solution: get the aurantiamarin reference substance appropriate, accurately weighed, add methyl alcohol and make the reference substance solution that every 1ml contains 50 μ g;
3) preparation of need testing solution: get described medicine, porphyrize, mixing is got 0.8g, accurately weighed, add zeyssatite 0.4g, grind well, put in tool plug conical flask, precision adds methyl alcohol 25ml, close plug, weighed weight, the ultrasonic processing of power 200W, frequency 40kHz 30 minutes lets cool, weighed weight is again supplied the weight of less loss with methyl alcohol, shake up, filter, get subsequent filtrate, and get final product;
4) draw respectively each 10 μ l of reference substance solution and need testing solution, the injection liquid chromatography is measured and get final product.
CN201310110682.7A 2013-04-01 2013-04-01 Quality control method of infant spleen tonifying medicament Active CN103163272B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310110682.7A CN103163272B (en) 2013-04-01 2013-04-01 Quality control method of infant spleen tonifying medicament

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310110682.7A CN103163272B (en) 2013-04-01 2013-04-01 Quality control method of infant spleen tonifying medicament

Publications (2)

Publication Number Publication Date
CN103163272A true CN103163272A (en) 2013-06-19
CN103163272B CN103163272B (en) 2015-05-20

Family

ID=48586531

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310110682.7A Active CN103163272B (en) 2013-04-01 2013-04-01 Quality control method of infant spleen tonifying medicament

Country Status (1)

Country Link
CN (1) CN103163272B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105028764A (en) * 2015-07-14 2015-11-11 张永霞 Spleen-fortifying malnutrition-removing tea soup and preparation method thereof
CN109342609A (en) * 2018-12-21 2019-02-15 国药控股星鲨制药(厦门)有限公司 Compound three-vitamines dextro calcium pantothenate syrup Chinese medicine liquid extract chemical component identification method
CN112051124A (en) * 2020-10-20 2020-12-08 东阿阿胶股份有限公司 Method for quickly identifying hylocereus undatus and/or liquorice in hylocereus undatus oral liquid

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102038902A (en) * 2009-10-26 2011-05-04 天津中新药业集团股份有限公司达仁堂制药厂 Quality control method of traditional Chinese medicine preparation xiaoerbaishou pill
CN102145146A (en) * 2007-09-13 2011-08-10 北京亚东生物制药有限公司 Method for detecting medicinal composition for treating urinary system diseases
CN102423352A (en) * 2011-12-13 2012-04-25 广东众生药业股份有限公司 Chinese medicinal granules for treating cardio-cerebrovascular diseases

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102145146A (en) * 2007-09-13 2011-08-10 北京亚东生物制药有限公司 Method for detecting medicinal composition for treating urinary system diseases
CN102038902A (en) * 2009-10-26 2011-05-04 天津中新药业集团股份有限公司达仁堂制药厂 Quality control method of traditional Chinese medicine preparation xiaoerbaishou pill
CN102423352A (en) * 2011-12-13 2012-04-25 广东众生药业股份有限公司 Chinese medicinal granules for treating cardio-cerebrovascular diseases

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
中国药典委员会 编: "《中华人民共和国药典:2010年版.一部》", 31 January 2010, article "山楂化滞丸、小儿化食丸、血脂灵片" *
嵇汝运 等 主编: "《药学大辞典》", 30 September 2006, article "熊果酸", pages: 1036 *
庞小雄 等: "HPLC法测定拈痛丸中橙皮苷的含量", 《中药材》, vol. 30, no. 6, 30 June 2007 (2007-06-30), pages 734 - 735 *
张士勇 等: "薄层扫描法测定酒制木瓜中熊果酸的含量", 《中医药临床杂志》, vol. 18, no. 4, 31 August 2006 (2006-08-31), pages 408 - 409 *
梁生旺 等 主编: "《中药制剂定量分析》", 30 September 1997, article "六、含熊果酸制剂分析", pages: 314-315 *
王林丽 等: "痛风利湿口服液质量标准研究", 《中国药业》, vol. 21, no. 15, 5 August 2012 (2012-08-05), pages 49 - 50 *
苏东林 等: "RP-HPLC法同时测定柑桔皮中橙皮苷和柚皮苷的含量", 《食品工业科技》, vol. 29, no. 06, 30 June 2008 (2008-06-30), pages 288 - 290 *
郑小平 等: "龙胆泻肝片的薄层鉴别方法", 《中国药业》, vol. 17, no. 16, 31 August 2008 (2008-08-31), pages 39 - 40 *
郜新莲: "小儿增食片质量标准研究", 《中医学报》, vol. 27, no. 1, 1 January 2012 (2012-01-01), pages 67 - 69 *
雷宁 等: "复方决明子胶囊的质量标准研究", 《中国药房》, vol. 22, no. 3, 19 January 2011 (2011-01-19), pages 255 - 257 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105028764A (en) * 2015-07-14 2015-11-11 张永霞 Spleen-fortifying malnutrition-removing tea soup and preparation method thereof
CN109342609A (en) * 2018-12-21 2019-02-15 国药控股星鲨制药(厦门)有限公司 Compound three-vitamines dextro calcium pantothenate syrup Chinese medicine liquid extract chemical component identification method
CN109342609B (en) * 2018-12-21 2021-04-20 国药控股星鲨制药(厦门)有限公司 Method for identifying chemical components of traditional Chinese medicine fluid extract of compound three-dimensional calcium D-pantothenate syrup
CN112051124A (en) * 2020-10-20 2020-12-08 东阿阿胶股份有限公司 Method for quickly identifying hylocereus undatus and/or liquorice in hylocereus undatus oral liquid

Also Published As

Publication number Publication date
CN103163272B (en) 2015-05-20

Similar Documents

Publication Publication Date Title
CN105842373B (en) A method of establishing the finger-print of the pharmaceutical preparation of honeysuckle
CN104398642A (en) Preparation and quality detection method of compound prescription cortex phellodendri chinensis fluid
CN103149320B (en) Quality control method of loins-strengthening and kidney-invigorating medicine
CN105259295A (en) Quality detection method for ginseng, cassia twig and poria cocos oral solution
CN103197027A (en) Quality control method of astragalus-leech capsules capable of regulating collaterals
CN108760945B (en) Detection method of astragalus membranaceus and astragalus membranaceus leucocyte increasing capsule
CN101444589A (en) Quality standard of Fenqing Wulin Wan and inspection method thereof
CN105301168B (en) The detection method of dredging collateral resolving sputum capsule
CN100437112C (en) Method for inspecting Chinese medicinal preparation quality in treatment of old man eyes dieases
CN104316613B (en) A kind of method for building up of dispelling wind detoxicating capsule finger printing
CN106501396B (en) A kind of detection method of hemorrhoid medicine index components content
CN103163272B (en) Quality control method of infant spleen tonifying medicament
CN103197026A (en) Quality control method of granules capable of strengthening and consolidating body resistance
CN104155383B (en) The detection method of blue or green Pu granule
CN100594034C (en) Blood-sugar lowering A preparation for treating diabetes, its preparation method and quality-control method
CN104849375B (en) The detection method of 'Juhong Tanke '
CN108459128A (en) A kind of method of quality control of danggui sini decoction composition
CN102068627A (en) Quality control method for Chinese medicine preparation Xinnaojing tabelets
CN110376291A (en) A kind of coptis reference extract and its preparation method and application
CN103344738B (en) Detection method of nine-component heart-calming particle
CN103575821A (en) Detection method of 14 chemical components in Tangminling preparation
CN106248860B (en) A kind of youngster's spleen is waken up the detection method of particle
CN108459129A (en) A kind of method of quality control of Tetrandra and Poria Decoction composition
CN108037200B (en) Quality detection method of kidney nourishing and tranquilizing pills
CN104345108B (en) Qualitative quantitative determination method for liver-heat-clearing tablet

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CP03 Change of name, title or address

Address after: 046000 Tunliu Kangzhuang high tech Industrial Park, Changzhi City, Shanxi Province

Patentee after: Shanxi Zhendong wuhetang Pharmaceutical Co.,Ltd.

Address before: 047100 No. 3, high tech Industrial Park, Tunliu County, Changzhi City, Shanxi Province

Patentee before: SHANXI ZHENDONG KAIYUAN PHARMACEUTICAL Co.,Ltd.

CP03 Change of name, title or address